Hudson Bay Capital Management’s AnaptysBio ANAB Stock Holding History

Hudson Bay Capital Management’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-55,000	Closed	-$1.38M	–	849
2024 Q2	$1.38M	Sell	55,000 -77,500	-58%	-$1.8M	0.01%	570
2024 Q1	$2.98M	Buy	132,500 +37,500	+39%	+$888K	0.02%	399
2023 Q4	$2.03M	Sell	95,000 -5,000	-5%	-$86.2K	0.01%	454
2023 Q3	$1.8M	Buy	100,000 +50,000	+100%	+$954K	0.01%	497
2023 Q2	$1.02M	Buy	+50,000	New	+$1.01M	0.01%	590
2020 Q2	–	Sell	-30,000	Closed	-$424K	–	490
2020 Q1	$424K	Sell	30,000 -20,000	-40%	-$303K	0.01%	377
2019 Q4	$813K	Sell	50,000 -50,700	-50%	-$1.2M	0.02%	329
2019 Q3	$3.52M	Buy	100,700 +18,200	+22%	+$866K	0.1%	196
2019 Q2	$4.66M	Buy	82,500 +22,500	+38%	+$1.62M	0.11%	182
2019 Q1	$4.38M	Buy	60,000 +30,000	+100%	+$2.07M	0.06%	304
2018 Q4	$1.91M	Buy	+30,000	New	+$2.23M	0.03%	519
2018 Q3	–	Sell	-47,037	Closed	-$3.34M	–	695
2018 Q2	$3.34M	Buy	+47,037	New	+$3.95M	0.05%	392

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hudson Bay Capital Management's ANAB Position: Q3 2024 in Review

Hudson Bay Capital Management sold out of AnaptysBio (ANAB) in Q3 2024, closing a stake of 55,000 shares — an estimated $1.38M sold.

Hudson Bay Capital Management first reported a position in ANAB in Q2 2018 and held it in 12 quarters. The position peaked at $4.66M in Q2 2019. 160 funds tracked by Wall St. Rank hold ANAB as of Q3 2024.

Hudson Bay Capital Management reported no remaining AnaptysBio position as of Q3 2024 after selling out during the quarter.
Hudson Bay Capital Management sold 55,000 AnaptysBio shares in Q3 2024, an estimated $1.38M.
Hudson Bay Capital Management first reported a position in AnaptysBio in Q2 2018 and held it in 12 quarters.
Hudson Bay Capital Management's AnaptysBio position peaked at $4.66M in Q2 2019.
160 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2024.

Based on Hudson Bay Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.